Penumbra (PEN) Cash & Current Investments (2014 - 2026)

Penumbra's (PEN) quarterly Cash & Current Investments came in at $615.7 million in Q1 2026, up 62.51% year-on-year from $378.8 million in Q1 2025, and up 13.0% on a QoQ basis from $544.8 million in Q4 2025.

Penumbra (PEN) Cash & Current Investments (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Cash & Current Investments data on file, last reported at $615.7 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments rose 62.51% year-over-year to $615.7 million in Q1 2026; TTM through Mar 2026 was $615.7 million, a 62.51% increase from a year earlier, with the FY2025 full-year figure at $544.8 million, up 60.18% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $615.7 million, up from $544.8 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for PEN reached as high as $615.7 million in Q1 2026 and fell as low as $184.4 million in Q3 2022.
  • Historically, Cash & Current Investments has averaged $323.2 million across 5 years, with a median of $291.0 million in 2024.
  • Across the five-year window, Cash & Current Investments plunged 30.91% in 2022 and soared 62.51% in 2026, its largest moves.
  • Year by year, Cash & Current Investments stood at $188.0 million in 2022, then surged by 53.8% to $289.2 million in 2023, then grew by 17.62% to $340.1 million in 2024, then soared by 60.18% to $544.8 million in 2025, then grew by 13.0% to $615.7 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $615.7 million in Q1 2026, $544.8 million in Q4 2025, and $470.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Abbott Laboratories 183.48 Bn 176.19 Bn 6.27 Bn 7.30 Bn
2 Stryker 129.11 Bn 126.23 Bn 3.81 Bn 2.88 Bn
3 Medtronic 108.35 Bn 99.13 Bn 6.41 Bn 9.22 Bn
4 Boston Scientific 68.68 Bn 67.22 Bn 3.61 Bn 1.45 Bn
5 Edwards Lifesciences 48.35 Bn 44.67 Bn 1.29 Bn 3.67 Bn
6 Dexcom 28.38 Bn 27.26 Bn 750.30 Mn 1.12 Bn
7 GE HealthCare Technologies 28.04 Bn 25.76 Bn 1.98 Bn 2.29 Bn
8 Smith & Nephew 26.92 Bn 26.35 Bn - 577.00 Mn
9 Koninklijke Philips 24.06 Bn 20.93 Bn 2.07 Bn 3.12 Bn
10 Penumbra 12.58 Bn 11.97 Bn 253.41 Mn 615.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 615.66 Mn
Dec 31, 2025 544.82 Mn
Sep 30, 2025 470.30 Mn
Jun 30, 2025 424.56 Mn
Mar 31, 2025 378.85 Mn
Dec 31, 2024 340.13 Mn
Sep 30, 2024 291.02 Mn
Jun 30, 2024 339.70 Mn
Mar 31, 2024 313.47 Mn
Dec 31, 2023 289.19 Mn
Sep 30, 2023 248.86 Mn
Jun 30, 2023 221.06 Mn
Mar 31, 2023 199.10 Mn
Dec 31, 2022 188.03 Mn
Sep 30, 2022 184.43 Mn
Jun 30, 2022 204.37 Mn
Mar 31, 2022 240.34 Mn
Dec 31, 2021 254.88 Mn
Sep 30, 2021 266.93 Mn
Jun 30, 2021 156.72 Mn